tiprankstipranks
Cabaletta Bio price target lowered to $34 from $35 at Wells Fargo
The Fly

Cabaletta Bio price target lowered to $34 from $35 at Wells Fargo

Wells Fargo lowered the firm’s price target on Cabaletta Bio to $34 from $35 and keeps an Overweight rating on the shares. The firm is “disappointed” there won’t be a more robust update for CABA-201 in the first half of 2024, but thinks this is largely priced in given the recent weakness, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles